Loading clinical trials...
Loading clinical trials...
Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Ulcerative Colitis Disease
Conditions
Interventions
Urinary PGEm level
fecal calprotectin
Locations
1
United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Start Date
November 1, 2006
Primary Completion Date
November 1, 2007
Completion Date
December 1, 2007
Last Updated
June 9, 2015
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Vanderbilt University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions